Studies indicate that women with HIV infection in the 
United States are inadequately screened for cervical 
dysplasia. However, few of these studies have included 
women in the southern United States, where HIV  
incidence is now concentrated. We performed a 
retrospective chart review of women with HIV infection in 
two HIV clinics in a large southern metropolitan area. To 
describe screening rates among women in care, only 
women with ≥2 primary care clinic visits during 2007 were 
included. We used log-binomial regression to estimate 
prevalence ratios and 95% confidence intervals of 
screening and to identify demographic, behavioral, and 
care-related factors associated with screening. Only 52% 
(258/498) of women in our study were screened during the 
year and only 29% (8/28) of women with ≤50 CD4 
cells/mm3. Factors associated with increased screening in 
unadjusted analyses included increased number of primary 
care visits (p<0.001), higher CD4 cell count (p<0.001), 
younger age (p=0.006) and Hispanic compared to non- 
Hispanic ethnicity (p<0.001). In adjusted analyses, women 
with ≥4 primary care visits were 21% more likely to be 
screened than women with <4 visits (adjusted prevalence 
ratio = 1.21; 95% confidence interval: 1.02–1.44). Women 
with CD4 cell counts <200 cells/mm3 were less likely to be screened than women with CD4 counts ≥350 cells/mm3 
(adjusted prevalence ratio: 0.77; 95% confidence interval: 
0.59–1.00). Rates of screening for cervical dysplasia were 
lower than those seen in similar care settings in other 
geographic areas in the United States. The number of HIV 
primary care visits, which has been associated with retention 
in care, was associated with screening prevalence. 
Interventions designed to improve retention in care may 
improve screening rates for cervical dysplasia as well.